Glucose Homeostasis and Incretin Effect T2DM in the Youth- a Study of the Malaysian Population
Glucose Homeostasis, Incretin Effect and Cardiovascular Risk Burden in T2DM in the Youth- a Study of the Malaysian Population
Sponsor: Institute for Medical Research, Malaysia
This observational or N/A phase trial investigates Diabetes Mellitus, Type 2 and is currently completed. Institute for Medical Research, Malaysia leads this study, which shows 8 recorded versions since 2013 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Feb 2020 — Jan 2021 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Feb 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Feb 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institute for Medical Research, Malaysia
- Institute of Neuroscience, Padova, Italy
- Penang Hospital, Malaysia
- Putrajaya Hospital, Malaysia
- RCSI & UCD Malaysia Campus
- Sarawak General Hospital
- Seberang Jaya Clinical Research Centre
- University of Copenhagen
For direct contact, visit the study record on ClinicalTrials.gov .